DBTX — Decibel Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall Cap

Annual balance sheet for Decibel Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	82.3	32.3	54.3	149	105
Net Total Accounts Receivable
Net Total Receivables	—	—	1.24	11.4	0
Prepaid Expenses
Total Current Assets	83.6	33.6	57.8	164	108
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.88	7.83	6.34	5.61	14.4
Long Term Investments
Other Long Term Assets
Total Assets	93.3	42.8	67.3	184	123
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11	9.45	19.4	20.5	22.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	35.8	27	29	42.8	41.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	57.5	15.8	38.3	142	81.8
Total Liabilities & Shareholders' Equity	93.3	42.8	67.3	184	123
Total Common Shares Outstanding